Leslie Eiland1, Thiyagarajan Thangavelu1, Andjela Drincic2. 1. Department of Internal medicine, Division of Diabetes, Endocrinology & Metabolism, University of Nebraska Medical Center, 984120 Nebraska Medical Center, Omaha, NE, 68198-4120, USA. 2. Department of Internal medicine, Division of Diabetes, Endocrinology & Metabolism, University of Nebraska Medical Center, 984120 Nebraska Medical Center, Omaha, NE, 68198-4120, USA. andjela.drincic@unmc.edu.
Abstract
PURPOSE OF REVIEW: To review the current state of diabetes technology adoption and describe impact on outcomes in the context of age, gender, and ethnicity. We will discuss barriers and propose solutions that may help facilitate the adoption. RECENT FINDINGS: We are witnessing rapid evolution and increase in adoption of diabetes technology in all its forms, including insulin delivery and glucose monitoring devices, mobile medical applications, and telemedicine. This technology has a great potential to improve diabetes-related outcomes, including acute and chronic complications as well as quality of life for people living with diabetes. However, currently available outcome data are showing modest efficacy and evidence for disparities when it comes to age, gender, and ethnicity. Despite multiple barriers, the adoption of technology is steadily increasing. It is clear that disparities exist in terms of access to and use of technology, but they may be at least in part driven by unmet needs of end users and as such are not unsurmountable. While more research is needed to identify the specific causes for the disparities, future development of diabetes technology that is based on adaptation of behavioral theories has a potential to address the gaps. The disparities can be lessened by understanding the needs of end users and with improvement in personalization of technology, allowing the right device to be used by the right patient. Targeted interventions to increase awareness and education and help navigate the processes involved in currently available technology may help diminish the gaps in health equity.
PURPOSE OF REVIEW: To review the current state of diabetes technology adoption and describe impact on outcomes in the context of age, gender, and ethnicity. We will discuss barriers and propose solutions that may help facilitate the adoption. RECENT FINDINGS: We are witnessing rapid evolution and increase in adoption of diabetes technology in all its forms, including insulin delivery and glucose monitoring devices, mobile medical applications, and telemedicine. This technology has a great potential to improve diabetes-related outcomes, including acute and chronic complications as well as quality of life for people living with diabetes. However, currently available outcome data are showing modest efficacy and evidence for disparities when it comes to age, gender, and ethnicity. Despite multiple barriers, the adoption of technology is steadily increasing. It is clear that disparities exist in terms of access to and use of technology, but they may be at least in part driven by unmet needs of end users and as such are not unsurmountable. While more research is needed to identify the specific causes for the disparities, future development of diabetes technology that is based on adaptation of behavioral theories has a potential to address the gaps. The disparities can be lessened by understanding the needs of end users and with improvement in personalization of technology, allowing the right device to be used by the right patient. Targeted interventions to increase awareness and education and help navigate the processes involved in currently available technology may help diminish the gaps in health equity.
Entities:
Keywords:
Age; Diabetes; Ethnicity; Gender; Health disparities; Technology
Authors: Persis V Commissariat; Claire T Boyle; Kellee M Miller; Manasa G Mantravadi; Daniel J DeSalvo; William V Tamborlane; Michelle A Van Name; Barbara J Anderson; Linda A DiMeglio; Lori M Laffel Journal: Diabetes Technol Ther Date: 2017-06-05 Impact factor: 6.118
Authors: Charlene C Quinn; Bilal Khokhar; Kelly Weed; Erik Barr; Ann L Gruber-Baldini Journal: Diabetes Technol Ther Date: 2015-02-18 Impact factor: 6.118
Authors: Robert A Vigersky; Stephanie J Fonda; Mary Chellappa; M Susan Walker; Nicole M Ehrhardt Journal: Diabetes Care Date: 2011-11-18 Impact factor: 19.112